2016

Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease Ophthalmic Technology Assessment

Visit USCO

Text Registration

Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease Ophthalmic Technology Assessment

Status

Published

on 17 Mar 2016

Year of Creation

2016

American Academy of Ophthalmology

Registration Number

TX0008237178

on 17 Mar 2016

The U.S. Copyright record (Registration Number: TX0008237178) dated 17 Mar 2016, pertains to an electronic file (eService) titled "Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease Ophthalmic Technology Assessment" created in 2016. The copyright holder is American Academy of Ophthalmology, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to American Academy of Ophthalmology.

American Academy of Ophthalmology

Application Details

Registration Number

TX0008237178

Registration Date

3/17/2016

Year of Creation

2016

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Corporate Authors

American Academy of Ophthalmology

Notes

Host Item Entry: Ophthalmology vol. 123, March 2016, p. 492-496

Statements

Application Title Statement: Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease Ophthalmic Technology Assessment

Author Statement: Edward J. Wladis Domicile: United States Authorship: text Elizabeth A. Bradley Domicile: United States Authorship: text Jurij R. Bilyk Domicile: United States Authorship: text Michael T. Yen Domicile: United States Authorship: text Louise A. Mawn Domicile: United States Authorship: text

Notes

Host Item Entry: Ophthalmology vol. 123, March 2016, p. 492-496

Statements

Application Title Statement: Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease Ophthalmic Technology Assessment

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.